Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice

Journal of Psychopharmacology

Volumn 11, Issue 3, 1997, Pages 211-218

  Da Rocha Jr , Mario A ^a,b   Puech, Alain J ^a   Thiébot, Marie Hélène ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Antidepressants; Anxiolytics; Forced swimming test; Mice; SSRIs

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ALPIDEM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CHLORDIAZEPOXIDE; CITALOPRAM; DIAZEPAM; DOPAMINE; FLUOXETINE; FLUVOXAMINE; INDALPINE; KETANSERIN; LORAZEPAM; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; NEUROLEPTIC AGENT; NORADRENALIN; PAROXETINE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIORIDAZINE; TRIAZOLAM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG EFFECT; FORCED SWIMMING TEST; GABAERGIC SYSTEM; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DIAZEPAM; DRUG INTERACTIONS; FLUMAZENIL; FLUOXETINE; GABA MODULATORS; MALE; MICE; MOTOR ACTIVITY; SEROTONIN UPTAKE INHIBITORS;

EID: 15144341301     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119701100303     Document Type: Article

References (42)

1. Abel E L (1993) Physiological correlates of the forced swim test in rats. Physiol Behav 54: 309-317
2. Abercrombie E D, Keefe K A, DiFrischia D S, Zigmond M J (1989) Differential effects of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52: 1655-1658
3. 2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Synapse 17: 173-181
4. Boissier J R, Simon P (1965) Action de la caféine sur la motilité de la souris. Archs Gen Psychiat 158: 212-221
5. Bolden-Watson C, Richelson E (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52: 1023-1029
6. Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19: 377-395
7. Borsini F, Meli A (1990) The forced swimming test: its contribution to the understanding of the mechanism of action of antidepressants. Adv Biosci 77: 63-76
8. 1C receptor function. Eur J Pharmac 203: 359-363
9. Bourin M, Hascoet M, Colombel M C, Redrobe J P, Baker G B (1996) Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems. Eur J Pharmac 6: 231-236
10. Bowen R C (1978) The effects of diazepam on the recovery of endogenously depressed patients. J Clin Pharmac 18: 280-284
11. Brady L S (1994) Stress, antidepressant drugs, and the locus coeruleus. Brain Res Bull 35: 545-556
12. Cassano G B, Conti L (1981) Some considerations on the role of benzodiazepines in the treatment of depression. Br J Clin Pharmac 11: 23S-29S
13. Cervo L, Grignaschi G, Rossi C, Samanin R (1991) Role of central serotonergic neurons on the effects of sertraline in rats in the forced swimming test. Eur J Pharmac 196: 217-222
14. 1A receptors mediate the effect of ipsapirone on punished responding in rats. Eur J Pharmac 284: 249-255
15. Cesana R, Ceci A, Ciprandi C, Borsini F (1993) Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice. J Pharm Pharmac 45: 473-475
16. 1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat. Pharmac Biochem Behav 48: 281-289
17. Costall B, Jones B J, Kelly M E, Naylor R J, Tomkins D M (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmac Biochem Behav 32: 777-785
18. Detke M J, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121: 66-72
19. 2-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on forced-swimming-induced immobility in mice. Jap J Pharmac 68: 71-75
20. 1A receptors. Eur J Pharmac 237: 283-291
21. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmac 115: 1064-1070
22. Haefely W, Pole P, Pieri L, Schaffner R, Laurent J P (1983) Neuropharmacology of benzodiazepines: Synaptic mechanisms and neural basis of action. In Costa E (ed.), The benzodiazepines: from molecular biology to clinical practice. Raven Press, New York, pp. 21-66
23. Hyttel J (1984) Experimental pharmacology of selective 5-HT reuptake inhibitors: differences and similarities. Clin Neuropharmac 7 (Suppl. 1): S466
24. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmac 3 (Suppl. 1): 19-26
25. Jordan S, Kramer G L, Zukas P K, Moeller M, Petty F (1994) In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18: 294-297
26. Kravitz H M, Fogg L, Fawcett J, Edwards J (1990) Antidepressant or antianxiety? A study of the efficacy of antidepressant medication. Psychiatr Res 32: 141-149
27. Laux G, Koenig W, Pfaff G (1988) Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics - A study comparing adjuvant treatment with oxazolam versus chlorprothixene. Pharmacopsychiatry 21: 87-92
28. Leonard B E (1994) Biochemical strategies for the development of antidepressants. CNS Drugs 1: 285-304
29. A/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology 34: 245-254
30. 1A receptors. Br J Pharmac 108: 669-677
31. 2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule. J Pharmac ExpTher 250: 52-59
32. Martin P, Thiébot M H, Puech A J (1990) Modèles animaux sensibles aux antidépresseurs: implication des systèmes sérotoninergiques et noradrénergiques centraux. Psychiat Psychobiol 5: 209-217
33. Nielsen C K (1996) Potentiation of the effect of selective serotonin reuptake inhibitors in the forced swimming test in mice. Biochem Pharmac 7 (Suppl. 1): 76-77
34. A receptor subunits in the rat CNS. J Comp Neurol 326: 193-216
35. Porsolt R D, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to anti-depressant treatment. Nature 266: 730-732
36. Porsolt R D, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmac 57: 201-210
37. Porsolt R D, Lenegre A, McArthur R A (1991) Pharmacological models of depression. In Olivier B, Slangen J L, Mos J (eds), Animal models in psychopharmacology. Birkhäuser-Verlag, Basle, pp. 137-159
38. Puech A J (1994) Intérêt de l'évaluation des comportements chez l'animal pour les psychotropes et en particulier pour les antidépresseurs. Encéphale XX: 247-249
39. Van Der Meersch-Mougeot V, Da Rocha M, Monier C, Diquet B, Puech A J, Thiébot M H (1993) Benzodiazepines reverse the antiimmobility effect of antidepressants in the forced swimming test in mice. Neuropharmacology 32: 439-446
40. Van Wijngaarden I, Tulp M T M, Soudijn W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmac 188: 301-312
41. Willner P (1990) Animal models of depression: an overview. Pharmac Ther 45: 425-445
42. Zivkovic B, Morel E, Joly D, Perrault G, Sanger D J, Lloyd K G (1990) Pharmacological and behavioral profile of alpidem as an anxiolytic. Pharmacopsychiatry 23: 108-113